fluoxetine and levodopa

fluoxetine has been researched along with levodopa in 31 studies

Research

Studies (31)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (9.68)	18.7374
1990's	10 (32.26)	18.2507
2000's	6 (19.35)	29.6817
2010's	12 (38.71)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ	1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ	1
Ekins, S; Williams, AJ; Xu, JJ	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Jones, GT; Moore, RA; Slater, IH	1
Jansen, EN; Kölling, P	1
Jackson, DM; Jenkins, OF	1
Jones, RS	1
Agid, Y; Blin, J; Bonnet, AM; Durif, F; Vidailhet, M	1
Blin, O; Fabre, N; Montastruc, JL; Rascol, A; Rascol, O; Senard, JM	1
Huszonek, JJ	1
Lauterbach, EC	1
Hesselink, JM	1
Cherin, P; Colvez, A; Deville de Periere, G; Sereni, D	1
Almeida, OP; Tamai, S	1
Allikmets, L; Matto, V; Skrebuhhova, T	1
Bhatia, KP; Marsden, CD; Mathen, D	1
Kannari, K; Matsunaga, M; Shen, H; Suda, T; Yamato, H	1
Bilbao Garay, J; Castilla Castellano, V; Dhimes Tejada, P; Mesa Plaza, N	1
Bagheri, H; Montastruc, JL; Schmitt, L	1
Araujo Silva, MT; Barbosa, ER; Bermpohl, F; Boggio, PS; Fregni, F; Mansur, CG; Marcolin, MA; Odebrecht Rosa, M; Pascual-Leone, A; Rigonatti, SP; Rosa, M; Rumi, DO	1
Arai, A; Baba, M; Kannari, K; Shen, H; Tomiyama, M	1
Linazasoro, G; Van Blercom, N	1
Ansorge, MS; Esposito, E; Gingrich, JA; Gray, N; Moore, H; Morelli, E; Rebello, TJ; Steele, K	1
Abe, M; Inden, M; Kitamura, Y; Minamino, H; Takata, K; Tooyama, I; Yoshimoto, K	1
Bishop, C; Buchta, W; Dickinson, SO; Eissa, S; Eskow Jaunarajs, KL; George, JA; Goldenberg, AA; Mohamed, M	1
Berrocoso, E; Mico, JA; Miguelez, C; Ugedo, L	1
Af Bjerkén, S; Gerhardt, GA; Nevalainen, N; Strömberg, I	1
Fitzgerald, PJ; Maren, S; Seemann, JR	1
Gore, C; Wu, C	1

Reviews

4 review(s) available for fluoxetine and levodopa

Article	Year
[Serotonin syndrome: report of a fatal case and review of the literature]. Revista clinica espanola, 2002, Volume: 202, Issue:4 Topics: Aged; Antiparkinson Agents; Carbidopa; Depressive Disorder, Major; Drug Combinations; Drug Synergism; Fatal Outcome; Fluoxetine; Humans; Levodopa; Male; Parkinson Disease; Selective Serotonin Reuptake Inhibitors; Selegiline; Serotonin Syndrome	2002
[Pathological gambling behavior in a patient with Parkinson's disease treated with levodopa and bromocriptine]. Revue neurologique, 2003, Volume: 159, Issue:4 Topics: Antidepressive Agents; Antiparkinson Agents; Bromocriptine; Citalopram; Depressive Disorder; Dopamine Agents; Female; Fluoxetine; Gambling; Humans; Levodopa; Middle Aged; Parkinson Disease	2003
Can fear extinction be enhanced? A review of pharmacological and behavioral findings. Brain research bulletin, 2014, Volume: 105 Topics: Animals; Conditioning, Classical; Extinction, Psychological; Fear; Fluoxetine; Humans; Levodopa; Neurotransmitter Agents; Propranolol; Yohimbine	2014
Medical Therapies of Amblyopia: Translational Research to Expand Our Treatment Armamentarium. Seminars in ophthalmology, 2016, Volume: 31, Issue:1-2 Topics: Amblyopia; Carbidopa; Cholinesterase Inhibitors; Donepezil; Dopamine Agonists; Drug Combinations; Fluoxetine; Humans; Indans; Levodopa; Neuronal Plasticity; Piperidines; Selective Serotonin Reuptake Inhibitors; Translational Research, Biomedical; Visual Cortex	2016

Trials

2 trial(s) available for fluoxetine and levodopa

Article	Year
Does fluoxetine aggravate Parkinson's disease? A pilot prospective study. Movement disorders : official journal of the Movement Disorder Society, 1995, Volume: 10, Issue:3 Topics: Aged; Drug Therapy, Combination; Female; Fluoxetine; Humans; Levodopa; Male; Neurologic Examination; Parkinson Disease; Parkinson Disease, Secondary; Pilot Projects; Prospective Studies; Treatment Outcome	1995
Effect of repetitive TMS and fluoxetine on cognitive function in patients with Parkinson's disease and concurrent depression. Movement disorders : official journal of the Movement Disorder Society, 2005, Volume: 20, Issue:9 Topics: Aged; Antiparkinson Agents; Cognition Disorders; Depressive Disorder, Major; Double-Blind Method; Female; Fluoxetine; Functional Laterality; Humans; Levodopa; Male; Neuropsychological Tests; Parkinson Disease; Periodicity; Prefrontal Cortex; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Transcranial Magnetic Stimulation	2005

Article

Year

Does fluoxetine aggravate Parkinson's disease? A pilot prospective study.

Movement disorders : official journal of the Movement Disorder Society, 1995, Volume: 10, Issue:3

Topics: Aged; Drug Therapy, Combination; Female; Fluoxetine; Humans; Levodopa; Male; Neurologic Examination; Parkinson Disease; Parkinson Disease, Secondary; Pilot Projects; Prospective Studies; Treatment Outcome

1995

Effect of repetitive TMS and fluoxetine on cognitive function in patients with Parkinson's disease and concurrent depression.

Movement disorders : official journal of the Movement Disorder Society, 2005, Volume: 20, Issue:9

Topics: Aged; Antiparkinson Agents; Cognition Disorders; Depressive Disorder, Major; Double-Blind Method; Female; Fluoxetine; Functional Laterality; Humans; Levodopa; Male; Neuropsychological Tests; Parkinson Disease; Periodicity; Prefrontal Cortex; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Transcranial Magnetic Stimulation

2005

Other Studies

25 other study(ies) available for fluoxetine and levodopa

Article	Year
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species. Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6 Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics	2010
Developing structure-activity relationships for the prediction of hepatotoxicity. Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes	2010
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12 Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands	2010
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Depression of REM sleep in cats by nisoxetine, a potential antidepressant drug. Psychopharmacology communications, 1976, Volume: 2, Issue:3 Topics: Animals; Cats; Depression, Chemical; Drug Interactions; Fluoxetine; Levodopa; Male; Nortriptyline; Phenyl Ethers; Propylamines; Serotonin; Sleep, REM; Time Factors	1976
[Parkinsonism following addition of fluoxetine to treatment with neuroleptics or carbamazepine]. Nederlands tijdschrift voor geneeskunde, 1992, Apr-11, Volume: 136, Issue:15 Topics: Depression; Female; Fluoxetine; Humans; Levodopa; Middle Aged; Parkinson Disease; Parkinson Disease, Secondary	1992
Bromocriptine potentiates the behavioural effects of directly and indirectly acting dopamine receptor agonists in mice. Naunyn-Schmiedeberg's archives of pharmacology, 1985, Volume: 331, Issue:1 Topics: alpha-Methyltyrosine; Animals; Bromocriptine; Desipramine; Drug Synergism; Fluoxetine; Haloperidol; Levodopa; Male; Methyltyrosines; Mice; Motor Activity; Nomifensine; Receptors, Dopamine; Reserpine	1985
In vivo pharmacological studies on the interactions between tryptamine and 5-hydroxytryptamine. British journal of pharmacology, 1981, Volume: 73, Issue:2 Topics: 5-Hydroxytryptophan; Animals; Behavior, Animal; Chickens; Deglutition; Female; Fluoxetine; Levodopa; Male; Mice; p-Chloroamphetamine; Rats; Serotonin; Tranylcypromine; Tryptamines	1981
Levodopa-induced dyskinesias are improved by fluoxetine. Neurology, 1995, Volume: 45, Issue:10 Topics: Antiparkinson Agents; Apomorphine; Dyskinesia, Drug-Induced; Fluoxetine; Humans; Levodopa; Middle Aged	1995
Anticholinergic effects in a depressed parkinsonian patient. Journal of geriatric psychiatry and neurology, 1995, Volume: 8, Issue:2 Topics: Aged; Benztropine; Carbidopa; Depressive Disorder; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fluoxetine; Humans; Levodopa; Male; Parkinson Disease; Treatment Outcome	1995
Dopaminergic hallucinosis with fluoxetine in Parkinson's disease. The American journal of psychiatry, 1993, Volume: 150, Issue:11 Topics: Aged; Bromocriptine; Carbidopa; Fluoxetine; Hallucinations; Humans; Levodopa; Male; Parkinson Disease; Visual Perception	1993
Serotonin and Parkinson's disease. The American journal of psychiatry, 1993, Volume: 150, Issue:5 Topics: Basal Ganglia Diseases; Depressive Disorder; Dopamine; Drug Therapy, Combination; Fluoxetine; Humans; Levodopa; Parkinson Disease; Serotonin; Tryptophan	1993
Risk of syncope in the elderly and consumption of drugs: a case-control study. Journal of clinical epidemiology, 1997, Volume: 50, Issue:3 Topics: Acepromazine; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Antiparkinson Agents; Antipsychotic Agents; Case-Control Studies; Drug Utilization; Drug-Related Side Effects and Adverse Reactions; Female; Fluoxetine; Haloperidol; Humans; Levodopa; Male; Matched-Pair Analysis; Pharmacoepidemiology; Risk; Syncope	1997
Nortriptyline for the treatment of depression in progressive supranuclear palsy. Journal of the American Geriatrics Society, 1997, Volume: 45, Issue:8 Topics: Adrenergic Uptake Inhibitors; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Depression; Dopamine Agents; Female; Fluoxetine; Humans; Levodopa; Nortriptyline; Remission Induction; Supranuclear Palsy, Progressive	1997
The effect of antidepressants on rat aggressive behavior in the electric footshock and apomorphine-induced aggressiveness paradigms. Methods and findings in experimental and clinical pharmacology, 1998, Volume: 20, Issue:4 Topics: Aggression; Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Apomorphine; Citalopram; Desipramine; Dopamine Agents; Electroshock; Fluoxetine; Levodopa; Male; Pain Measurement; Rats; Rats, Wistar; Tryptophan	1998
SSRI-induced reversal of levodopa benefit in two patients with dopa-responsive dystonia. Movement disorders : official journal of the Movement Disorder Society, 1999, Volume: 14, Issue:5 Topics: Adult; Antiparkinson Agents; Dystonia; Female; Fluoxetine; Humans; Levodopa; Recurrence; Selective Serotonin Reuptake Inhibitors; Stress, Psychological	1999
Fluoxetine reduces L-DOPA-derived extracellular DA in the 6-OHDA-lesioned rat striatum. Neuroreport, 2001, May-08, Volume: 12, Issue:6 Topics: Adrenergic Agents; Animals; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Dopamine Agents; Extracellular Space; Fluoxetine; Levodopa; Male; Parkinson Disease; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors	2001
Reuptake of L-DOPA-derived extracellular dopamine in the striatum with dopaminergic denervation via serotonin transporters. Neuroscience letters, 2006, Jul-10, Volume: 402, Issue:1-2 Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Drug Interactions; Extracellular Fluid; Fluoxetine; Homovanillic Acid; Levodopa; Male; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins	2006
Severe stuttering and motor tics responsive to cocaine. Parkinsonism & related disorders, 2007, Volume: 13, Issue:1 Topics: Adult; Cocaine; Dopamine Agonists; Fluoxetine; Humans; Levodopa; Male; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Stuttering; Tics	2007
Chronic 5-HT transporter blockade reduces DA signaling to elicit basal ganglia dysfunction. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2011, Nov-02, Volume: 31, Issue:44 Topics: 3,4-Dihydroxyphenylacetic Acid; Age Factors; Animals; Animals, Newborn; Basal Ganglia; Cell Count; Chromatography, High Pressure Liquid; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Exploratory Behavior; Fluoxetine; Homovanillic Acid; Levodopa; Male; Mice; Mice, Transgenic; Movement Disorders; Psychomotor Performance; Random Allocation; Rotarod Performance Test; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Signal Transduction; Substantia Nigra; Ventral Tegmental Area	2011
Effect of selective serotonin reuptake inhibitors via 5-HT1A receptors on L-DOPA-induced rotational behavior in a hemiparkinsonian rat model. Journal of pharmacological sciences, 2012, Volume: 119, Issue:1 Topics: Animals; Behavior, Animal; Corpus Striatum; Dopaminergic Neurons; Fluoxetine; Histones; Levodopa; Male; MAP Kinase Signaling System; Oxidopamine; Parkinson Disease; Phosphorylation; Piperazines; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1A; Selective Serotonin Reuptake Inhibitors; Serotonergic Neurons; Serotonin; Serotonin 5-HT1 Receptor Antagonists; Substantia Nigra; Tyrosine 3-Monooxygenase	2012
Serotonin transporter inhibition attenuates l-DOPA-induced dyskinesia without compromising l-DOPA efficacy in hemi-parkinsonian rats. The European journal of neuroscience, 2012, Volume: 36, Issue:6 Topics: Animals; Antiparkinson Agents; Apomorphine; Biogenic Monoamines; Citalopram; Corpus Striatum; Dyskinesia, Drug-Induced; Fluoxetine; Levodopa; Male; Parkinsonian Disorders; Paroxetine; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors	2012
L-DOPA modifies the antidepressant-like effects of reboxetine and fluoxetine in rats. Neuropharmacology, 2013, Volume: 67 Topics: Animals; Antidepressive Agents; Contraindications; Depression; Drug Therapy, Combination; Fluoxetine; Levodopa; Locus Coeruleus; Male; Morpholines; Motor Activity; Rats; Rats, Sprague-Dawley; Reboxetine; Treatment Outcome	2013
Serotonergic nerve fibers in L-DOPA-derived dopamine release and dyskinesia. Neuroscience, 2014, Feb-28, Volume: 260 Topics: Animals; Corpus Striatum; Dopamine; Dyskinesia, Drug-Induced; Female; Fluoxetine; Levodopa; Nerve Fibers; Rats; Rats, Sprague-Dawley; Serotonergic Neurons; Serotonin Plasma Membrane Transport Proteins	2014